Literature DB >> 9129116

Intracytoplasmic inclusion bodies of the substantia nigra in myotonic dystrophy. Immunohistochemical observations.

S Ono1, K Takahashi, Y Fukuoka, K Jinnai, F Kanda, H Kurisaki, S Mitake, T Inagaki, K Nagao.   

Abstract

We recently reported a significantly higher incidence of intracytoplasmic inclusion bodies (IIBs) of the substantia nigra in patients with myotonic dystrophy (MyD) than in age-matched controls. The changes are, per se, not specific, since a small percentage of disease and normal controls also showed similar inclusions. To elucidate the pathological significance of the inclusion in MyD, we studied immunohistochemical characteristics of IIBs of the substantia nigra in eight patients with MyD. Many IIBs showed moderately intense immunoreactivity for ubiquitin, microtubule-associated protein (MAP) 1 and MAP 2. However, the IIBs did not react with any of the following: anti-neurofilament protein antibodies (Abs) (68, 160 and 200 kDa), anti-neuron-specific enolase antibody (Ab), anti-tau Ab, anti-tubulin Abs (alpha and beta), anti-paired helical filament Ab, anti-actin Ab, anti-phosphorylated epitope of neurofilaments Ab, anti-synaptophysin Ab, anti-myelin basic protein Ab, anti-actin Ab and anti-glial fibrillary acidic protein Ab. Our results suggest that IIBs of the substantia nigra in MyD are related to an alteration of neuronal cytoskeleton metabolism affecting microtubular proteins in conjunction with activation of ubiquitin proteolytic systems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129116     DOI: 10.1016/s0022-510x(96)05342-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  1 in total

1.  A Patient with Myotonic Dystrophy Type 1 Presenting as Parkinsonism.

Authors:  Ji-Hyun Choi; Jee-Young Lee; Han-Joon Kim; Beomseok Jeon
Journal:  J Mov Disord       Date:  2018-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.